Recent study showed that ACC plays an important role in the progression of NAFLD and inhibitory of ACC could be an attractive approach to treating NASH (Alkhouri et al. 2020; Sheng et al. 2019). The gene discussed is ACACA; the disease is metabolic dysfunction-associated steatotic liver disease.